LifeSci Capital initiated coverage of Oculis (OCS) with an Outperform rating and $55 price target
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OCS:
- Oculis price target lowered to $29 from $30 at BofA
- 3 Best Stocks to Buy Now, 11/11/2025, According to Top Analysts
- Oculis price target raised to $42 from $36 at H.C. Wainwright
- Oculis Holding: Promising Pipeline Developments and Strong Financial Position Support Buy Rating
- Oculis Holding AG Reports Q3 2025 Financial Progress